Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

BACKGROUND: International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We estimate mean life years gained using different treatment indications in low inco...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Johansson, Kjell Arne, Robberstad, Bjarne, Norheim, Ole Frithjof
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2836271/
https://ncbi.nlm.nih.gov/pubmed/20180966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia